Subscribe for the newsletter
Sign in
Articles
Expert Interviews
Roundtable
Press Releases
Videos
The Road To Series
Market Research
Thought Leaders
More
Discovery
Small Molecules
Biologics
Advanced Therapies
Manufacturing
Supply Chain
Clinical Trials
Technologies
Financing
BIOVECTRA
Sort By
Newest First
1 / 2
1 / 2
Commitment to ESG Principles
How can pharmaceutical and biopharmaceutical companies demonstrate their commitment to ESG principles in manufacturing?
Pharma's Almanac
PAO-03-24-CL-03
March 08, 2024
Process Chemistry
Enabling Client Success with Complementary Services Built upon a Strong Chemistry Foundation
Jean-Francois Vincent-Rocan, Ph.D.
BIOVECTRA
PAO-12-23-CL-02
December 13, 2023
International Markets
In what international markets do you anticipate significant developments in the near future?
Pharma's Almanac
PAO-01-23-RT-02
January 31, 2023
Disruptive Technology
What do you view as the most disruptive or transformational technology or development on the horizon?
Pharma's Almanac
PAO-01-23-RT-01
January 31, 2023
mRNA
Leveraging Existing Technologies with New Dedicated Facilities for mRNA Projects
Scott Doncaster; Marc Sauer, Ph.D.
BIOVECTRA
PAO-02-022-CL-07
March 12, 2022
CDMO
Looking to Another 50 Years of Growth
Heather Delage; Oliver Technow
BIOVECTRA
PAO-02-22-R250-01
February 14, 2022
mRNA Vaccines
BIOVECTRA mRNA Vaccine and Biomanufacturing Facility Announced
BIOVECTRA
PR-M11-21-02
November 18, 2021
Single-Use Technology
Facilitating Clinical Manufacturing of Recombinant Proteins with Large-Scale Single-Use Fermentation Technology
Scott Doncaster; Cameron Graham; Neil Morrison
BIOVECTRA
PAO-10-21-CL-08-778
October 20, 2021
Rebranding
BIOVECTRA Inc. Looks Inward for New Brand: It’s All About Care
BIOVECTRA
PR-M06-21-013
June 04, 2021
Branding
BioVectra's Strategic Brand Update
Oliver Technow
BIOVECTRA
PTV-06-21-CL-001
June 02, 2021
Strategic Growth
Planning for Growth as Blockbusters Give Way to Personalized Medicine
BIOVECTRA
PAO-04-22-R221-54
April 29, 2021
Partnership
BioVectra and PhaseBio Discuss Creating an Optimal Partnership
Oliver Technow; David Alvaro, Ph.D.; Jonathan Mow
BIOVECTRA
PTV-04-21-CL-001
April 15, 2021
Supply Agreement
PhaseBio Pharmaceuticals and BioVectra Enter into Supply Agreement to Support Development and Commercialization of Bentracimab
BIOVECTRA
PR-M11-20-048
March 11, 2021
Meeting Two Trip Sponsors in Bratislava
Nigel Walker
Nice Insight
PA1144
December 09, 2020
Complex Manufacturing
Enabling Commercial Manufacturing for Highly Complex Small Molecule Drugs Through Process Engineering and Technological Innovation
Scott Doncaster; Clarke MacDonald
BIOVECTRA
PAP-Q1-20-CL-017
March 19, 2020
Recruitment
Living in Canada’s Coastal Paradise
BIOVECTRA
PAP-Q3-19-CL-004
October 28, 2019
Transaction
Mallinckrodt Agrees to Sell BioVectra Inc. to H.I.G. Capital for $250 Million
BIOVECTRA
PR-M09-19-NI-037
September 13, 2019
Expansion
Announcing Expansion for Enhanced Capabilities
Heather Delage
BIOVECTRA
PTV-M08-19-BIO-004
August 19, 2019
Company Overview
Come Home to BioVectra
BIOVECTRA
PAP-Q2-2019-CL-008
May 24, 2019
Small Molecule API
Supporting Client Projects for CDMO Success
Marc Sauer, Ph.D.; Mark Wellman
BIOVECTRA
PAP-Q1-2019-CL-030
March 12, 2019
